Parvovirus associated fulminant hepatic failure and aplastic anemia treated successfully with liver and bone marrow transplantation. A report of two cases

American Journal of Transplantation

Volumn 14, Issue 11, 2014, Pages 2645-2650

  Bathla, L ^a   Grant, W J ^b   Mercer, D F ^b   Vargas, L M ^b   Gebhart, C L ^b   Langnas, A N ^b  

^a Methodist Specialty and Transplant Hospital   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bone marrow hematopoietic stem cell transplantation; clinical research practice; fulminant hepatic failure; liver transplantation hepatology; liver transplantation: living donor

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; ERYTHROPOIETIN; FERRITIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IRON CHELATING AGENT; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA; BACTERIAL DNA; PRIMER DNA;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BILE LEAKAGE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; CONSERVATIVE TREATMENT; DIARRHEA; ERYTHROCYTE TRANSFUSION; FERRITIN BLOOD LEVEL; FULMINANT HEPATIC FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; IRON CHELATION; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PANCYTOPENIA; PARVOVIRUS INFECTION; PERCUTANEOUS DRAINAGE; POLYMERASE CHAIN REACTION; RASH; SCHOOL CHILD; THROMBOCYTE TRANSFUSION; VIRUS DIAGNOSIS; WHOLE BODY RADIATION; ANEMIA, APLASTIC; GENETICS; ISOLATION AND PURIFICATION; LIVER FAILURE, ACUTE; NUCLEOTIDE SEQUENCE; PATHOGENICITY; VIROLOGY;

ADOLESCENT; ANEMIA, APLASTIC; BASE SEQUENCE; BONE MARROW TRANSPLANTATION; CHILD; DNA PRIMERS; DNA, BACTERIAL; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; PARVOVIRUS B19, HUMAN;

EID: 84911416581     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12857     Document Type: Article

References (27)

1. Pikis A, Kavaliotis J, Manios S., Incidence of aplastic anemia in viral hepatitis in children. Scand J Infect Dis 1988; 20: 109-110.
2. Tzakis AG, Arditi M, Whintington PF, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 1988; 319: 393-396.
3. Cattral MS, Langnas AN, Markin RS, et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 1994; 20: 813-818.
4. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS., Hepatitis-associated aplastic anemia. N Engl J Med 1997; 336: 1059-1064.
5. Kawahara K, Storb R, Sanders J, Petersen FB., Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis. Blood 1991; 78: 1140-1143.
6. Dugan MJ, Rouch DA, Akard LP, et al. Successful allogeneic bone marrow transplantation in an adult with aplastic anemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Bone Marrow Transplant 1993; 12: 417-419.
7. Trede NS, Warwick AB, Rosoff PM, Rohrer R, Bierer BE, Guinan E., Tacrolimus (FK506) in allogenic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. Bone Marrow Transplant 1997; 20: 257-260.
8. Hagglund H, Winiarski J, Ringden O, Sparrelid E, Ericzon BG., Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Transplantation 1997; 64: 1207-1208.
9. Perkins JL, Neglia JP, Ramsay NKC, Davies SM., Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: Long-term follow-up and outcome. Bone Marrow Transplant 2001; 28: 523-526.
10. Stachel D, Schmid I, Lang T, Haas RJ, Otte JB., Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: Implications for clinical management and immune tolerance. Transpl Int 2002; 15: 39-44.
11. Umeda K, Adachi S, Watanabe K, Kimura N, Lin Y, Nakahata T., Successful hematopoietic stem cell transplantation for aplastic anemia following living-related liver transplantation. Bone Marrow Transplant 2002; 30: 531-534.
12. Molina RA, Katzir L, Rhee C, Ingram-Drake L, Krogstad P, Martin MG., Early evidence of bone marrow dysfunction in children with indeterminate fulminant hepatic failure who ultimately develop aplastic anemia. Am J Transplant 2004; 4: 1656-1661.
13. Hadzic N, Height S, Ball S, et al. Evolution in the management of acute liver failure-associated aplastic anemia in children: A single center experience. J Hepatol 2008; 48: 68-73.
14. Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ., Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 1999; 144: 1713-1724.
15. Langnas AN, Markin RS, Cattral MS, Naides SJ., Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatol 1995; 22: 1661-1665.
16. Pardi DS, Romero Y, Mertz LE, Douglas DD., Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: A report of two cases and a review of the literature. Am J Gastroenterol 1998; 93: 468-470.
17. Sokal EM, Melchior M, Cornu C, et al. Acute parvovirus B19 infection associated with fulminant hepatitis of favorable prognosis in young children. Lancet 1998; 352: 1739-1741.
18. Wong S, Young NS, Brown KE., Prevalence of parvovirus B19 in liver tissue: No association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 2003; 187: 1581-1586.
19. Hamon MD, Newland AC, Anderson MJ., Severe aplastic anemia after parvovirus infection in the absence of underlying hemolytic anemia. J Clin Pathol 1988; 109: 695-704.
20. Osaki M, Matsubara K, Iwasaki T, et al. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Ann Hematol 1999; 78: 83-86.
21. Kaptan K, Beyan C, Ural AU, et al. Successful treatment of severe aplastic anemia associated with human parvovirus B19 and Epstein-Barr virus in a healthy subject with allo-BMT. Am J Hematol 2001; 67: 252-255.
22. Schlitt HJ, Ringe B, Rodeck B, Burdelski M, Kuse E, Pichlmayr R., Bone marrow dysfunction after liver transplantation for fulminant non-A, non-B hepatitis: High risk for young patients. Transplantation 1992; 54: 936-937.
23. Champlin R, Ho W, Gale RP., Antithymocyte globulin treatment in patients with aplastic anemia. N Engl J Med 1983; 308: 113-118.
24. Shannon K, Koehne W, Heyman MB, Koerper MA., Relapsing post-hepatitis aplastic anemia. Clin Ped 1990; 29: 25-29.
25. Goss JA, Schiller GJ, Martin P, et al. Aplastic anemia complicating orthotopic liver transplantation. Hepatology 1997; 26: 865-869.
26. Ruutu T, Eriksson B, Remes K, et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogenic stem cell transplantation. Blood 2002; 100: 1977-1983.
27. Corbacioglu S., The prospective study on the incidence and outcome of VOD with the prophylactic use of defibrotide in pediatric stem cell transplantation has completed enrollment: Update on the VOD-DF study. Bone Marrow Transplant 2009; 43: S34-S35.